RENI, MICHELE
RENI, MICHELE
Facoltà di Medicina e Chirurgia
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
2016-01-01 Reni, Michele; Dugnani, Erica; Cereda, Stefano; Belli, Carmen; Balzano, Gianpaolo; Nicoletti, Roberto; Liberati, Daniela; Pasquale, Valentina; Scavini, Marina; Maggiora, Paola; Sordi, Valeria; Lampasona, Vito; Ceraulo, Domenica; Di Terlizzi, Gaetano; Doglioni, C; Falconi, Massimo; Piemonti, Lorenzo
3D conformal radiotherapy significantly reduces toxicity of post-prostatectomy adjuvant or salvage irradiation
2000-01-01 Cozzarini, C; Fiorino, C; Mandelli, D; Campagnoli, E; Fallini, M; Reni, M; Ceresoli, Gl; Bolognesi, A; Pellegrini, D; Calandrino, R; Calori, G; Villa, E
A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma
2022-01-01 Ferrara, Benedetta; Dugnani, Erica; Sordi, Valeria; Pasquale, Valentina; Pellegrini, Silvia; Reni, Michele; Balzano, Gianpaolo; Piemonti, Lorenzo
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile
2004-01-01 Monti, P; Marchesi, F; Reni, M; Mercalli, A; Sordi, V; Zerbi, A; Balzano, G; Di Carlo, V; Allavena, P; Piemonti, Lorenzo
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care
2021-01-01 Balzano, G.; Guarneri, G.; Pecorelli, N.; Reni, M.; Capurso, G.; Falconi, M.
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia
2005-01-01 Brandes, Aa; Cavallo, G; Reni, M; Tosoni, A; Nicolardi, L; Scopece, L; Franceschi, E; Sotti, G; Talacchi, A; Turazzi, S; Ermani, M
A MULTICENTER RETROSPECTIVE STUDY OF CHEMOTHERAPY IN ADULTS WITH EPENDYMOMA. GICNO (GRUPPO ITALIANO COOPERATIVO NEURO-ONCOLOGIA)
2004-01-01 Tosoni, A; Cavallo, G; Reni, M; Ermani, M; Nicolardi, L; Longhini, M; Franceschi, E; Scopece, L; Mazza, E; Brandes, Aa
A multicenter study of the prognosis and treatment of adult brain ependymal tumors
2004-01-01 Reni, M; Brandes, Aa; Vavassori, V; Cavallo, G; Casagrande, F; Vastola, F; Magli, A; Franzin, A; Basso, U; Villa, E
A multicenter study of treatment of primary CNS lymphoma
2002-01-01 Ferreri, Ajm; Reni, M; Pasini, F; Calderoni, A; Tirelli, U; Pivnik, A; Aondio, Gm; Ferrarese, F; Gomez, H; Ponzoni, Maurilio; Borisch, B; Berger, F; Chassagne, C; Iuzzolino, P; Carbone, A; Weis, J; Pedrinis, E; Motta, T; Jouvet, A; Barbui, T; Cavalli, F; Blay, Jy
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE
2010-01-01 Licata, G; Foppoli, M; Corazzelli, G; Zucca, E; Stelitano, C; Zaja, F; Fava, S; Paolini, R; Franzin, A; Politi, L; Ponzoni, Maurilio; Caligaris Cappio, F; Reni, M; Ferreri, A.
A phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced gallbladder, biliary tract, and ampulla of Vater adenocarcinoma, preliminary results
2002-01-01 Passoni, P; Reni, M; Ceresoli, Gl; Et, Al.
A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma
2012-01-01 Belli, C; Cereda, S; Piemonti, L; D’Incalci, M; Allavena, P; Miggiano, C; Rognone, A; Fugazza, C; Longoni, S; Reni, M
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants
2024-01-01 Carconi, C.; Bosi, C.; Scartozzi, M.; Cergnul, M.; Cinausero, M.; Faloppi, L.; Garajova, I.; Lonardi, S.; Pecora, I.; Pisanu, L.; Spadi, R.; Spallanzani, A.; Peretti, U.; Macchini, M.; Orsi, G.; Reni, M.
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients
2014-01-01 Maftouh, ; Avan, ; Funel, ; Paolicchi, ; Vasile, ; Pacetti, ; Vaccaro, ; Faviana, ; Campani, ; Caponi, ; Mambrini, ; Boggi, ; Cantore, ; Milella, ; Peters, ; G., J.; Reni, M; Giovannetti,
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
2007-01-01 Mercalli, A; Sordi, V; Formicola, R; Dandrea, M; Beghelli, S; Scarpa, A; Di Carlo, V; Reni, M; Piemonti, Lorenzo
A preoperative score to predict early death after pancreatic cancer resection
2017-01-01 Balzano, Gianpaolo; Dugnani, Erica; Crippa, Stefano; Scavini, Marina; Pasquale, Valentina; Aleotti, Francesca; Liberati, Daniela; Gandolfi, Alessandra; Belfiori, Giulio; Reni, Michele; Doglioni, Claudio; Ruffo, Giacomo; Marmorale, Cristina; Falconi, Massimo; Piemonti, Lorenzo
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
2018-01-01 Reni, M.; Zanon, S.; Balzano, G.; Passoni, P.; Pirche, C.; Chiaravalli, M.; Fugazza, C.; Ceraulo, D.; Nicoletti, R.; Arcidiacono, P. G.; Macchin, M.; Peretti, U.; Castoldi, R.; Doglioni, C.; Falconi, M.; Partell, S.; Gianni, L
A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer
2009-01-01 Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).
2012-01-01 Reni, M; Cereda, S; Rognone, A; Belli, C; Ghidini, M; Longoni, S; Fugazza, C; Rezzonico, S; Passoni, P; Slim, N; Balzano, G; Nicoletti, R; Cappio, S; Doglioni, Claudio; Villa, E.
A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXEL
2009-01-01 Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial | 1-gen-2016 | Reni, Michele; Dugnani, Erica; Cereda, Stefano; Belli, Carmen; Balzano, Gianpaolo; Nicoletti, Roberto; Liberati, Daniela; Pasquale, Valentina; Scavini, Marina; Maggiora, Paola; Sordi, Valeria; Lampasona, Vito; Ceraulo, Domenica; Di Terlizzi, Gaetano; Doglioni, C; Falconi, Massimo; Piemonti, Lorenzo | |
| 3D conformal radiotherapy significantly reduces toxicity of post-prostatectomy adjuvant or salvage irradiation | 1-gen-2000 | Cozzarini, C; Fiorino, C; Mandelli, D; Campagnoli, E; Fallini, M; Reni, M; Ceresoli, Gl; Bolognesi, A; Pellegrini, D; Calandrino, R; Calori, G; Villa, E | |
| A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma | 1-gen-2022 | Ferrara, Benedetta; Dugnani, Erica; Sordi, Valeria; Pasquale, Valentina; Pellegrini, Silvia; Reni, Michele; Balzano, Gianpaolo; Piemonti, Lorenzo | |
| A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile | 1-gen-2004 | Monti, P; Marchesi, F; Reni, M; Mercalli, A; Sordi, V; Zerbi, A; Balzano, G; Di Carlo, V; Allavena, P; Piemonti, Lorenzo | |
| A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care | 1-gen-2021 | Balzano, G.; Guarneri, G.; Pecorelli, N.; Reni, M.; Capurso, G.; Falconi, M. | |
| A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia | 1-gen-2005 | Brandes, Aa; Cavallo, G; Reni, M; Tosoni, A; Nicolardi, L; Scopece, L; Franceschi, E; Sotti, G; Talacchi, A; Turazzi, S; Ermani, M | |
| A MULTICENTER RETROSPECTIVE STUDY OF CHEMOTHERAPY IN ADULTS WITH EPENDYMOMA. GICNO (GRUPPO ITALIANO COOPERATIVO NEURO-ONCOLOGIA) | 1-gen-2004 | Tosoni, A; Cavallo, G; Reni, M; Ermani, M; Nicolardi, L; Longhini, M; Franceschi, E; Scopece, L; Mazza, E; Brandes, Aa | |
| A multicenter study of the prognosis and treatment of adult brain ependymal tumors | 1-gen-2004 | Reni, M; Brandes, Aa; Vavassori, V; Cavallo, G; Casagrande, F; Vastola, F; Magli, A; Franzin, A; Basso, U; Villa, E | |
| A multicenter study of treatment of primary CNS lymphoma | 1-gen-2002 | Ferreri, Ajm; Reni, M; Pasini, F; Calderoni, A; Tirelli, U; Pivnik, A; Aondio, Gm; Ferrarese, F; Gomez, H; Ponzoni, Maurilio; Borisch, B; Berger, F; Chassagne, C; Iuzzolino, P; Carbone, A; Weis, J; Pedrinis, E; Motta, T; Jouvet, A; Barbui, T; Cavalli, F; Blay, Jy | |
| A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE | 1-gen-2010 | Licata, G; Foppoli, M; Corazzelli, G; Zucca, E; Stelitano, C; Zaja, F; Fava, S; Paolini, R; Franzin, A; Politi, L; Ponzoni, Maurilio; Caligaris Cappio, F; Reni, M; Ferreri, A. | |
| A phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced gallbladder, biliary tract, and ampulla of Vater adenocarcinoma, preliminary results | 1-gen-2002 | Passoni, P; Reni, M; Ceresoli, Gl; Et, Al. | |
| A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma | 1-gen-2012 | Belli, C; Cereda, S; Piemonti, L; D’Incalci, M; Allavena, P; Miggiano, C; Rognone, A; Fugazza, C; Longoni, S; Reni, M | |
| A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants | 1-gen-2024 | Carconi, C.; Bosi, C.; Scartozzi, M.; Cergnul, M.; Cinausero, M.; Faloppi, L.; Garajova, I.; Lonardi, S.; Pecora, I.; Pisanu, L.; Spadi, R.; Spallanzani, A.; Peretti, U.; Macchini, M.; Orsi, G.; Reni, M. | |
| A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients | 1-gen-2014 | Maftouh, ; Avan, ; Funel, ; Paolicchi, ; Vasile, ; Pacetti, ; Vaccaro, ; Faviana, ; Campani, ; Caponi, ; Mambrini, ; Boggi, ; Cantore, ; Milella, ; Peters, ; G., J.; Reni, M; Giovannetti, | |
| A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer | 1-gen-2007 | Mercalli, A; Sordi, V; Formicola, R; Dandrea, M; Beghelli, S; Scarpa, A; Di Carlo, V; Reni, M; Piemonti, Lorenzo | |
| A preoperative score to predict early death after pancreatic cancer resection | 1-gen-2017 | Balzano, Gianpaolo; Dugnani, Erica; Crippa, Stefano; Scavini, Marina; Pasquale, Valentina; Aleotti, Francesca; Liberati, Daniela; Gandolfi, Alessandra; Belfiori, Giulio; Reni, Michele; Doglioni, Claudio; Ruffo, Giacomo; Marmorale, Cristina; Falconi, Massimo; Piemonti, Lorenzo | |
| A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma | 1-gen-2018 | Reni, M.; Zanon, S.; Balzano, G.; Passoni, P.; Pirche, C.; Chiaravalli, M.; Fugazza, C.; Ceraulo, D.; Nicoletti, R.; Arcidiacono, P. G.; Macchin, M.; Peretti, U.; Castoldi, R.; Doglioni, C.; Falconi, M.; Partell, S.; Gianni, L | |
| A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer | 1-gen-2009 | Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E | |
| A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). | 1-gen-2012 | Reni, M; Cereda, S; Rognone, A; Belli, C; Ghidini, M; Longoni, S; Fugazza, C; Rezzonico, S; Passoni, P; Slim, N; Balzano, G; Nicoletti, R; Cappio, S; Doglioni, Claudio; Villa, E. | |
| A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXEL | 1-gen-2009 | Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E |